1. Martín-Morales, Lorena, Feldman, Michal, Vershinin, Zlata, Caldés, Trinidad, Levy, Dan. . SETD6 dominant negative mutation in familial colorectal cancer type X. In Human molecular genetics, 26, 4481-4493. doi:10.1093/hmg/ddx336. https://pubmed.ncbi.nlm.nih.gov/28973356/
2. O'Neill, Daniel J, Williamson, Stuart Charles, Alkharaif, Dhuha, Gingras, Anne-Claude, Binda, Olivier. 2014. SETD6 controls the expression of estrogen-responsive genes and proliferation of breast carcinoma cells. In Epigenetics, 9, 942-50. doi:10.4161/epi.28864. https://pubmed.ncbi.nlm.nih.gov/24751716/
3. Chen, Ayelet, Feldman, Michal, Vershinin, Zlata, Levy, Dan. 2016. SETD6 is a negative regulator of oxidative stress response. In Biochimica et biophysica acta, 1859, 420-7. doi:10.1016/j.bbagrm.2016.01.003. https://pubmed.ncbi.nlm.nih.gov/26780326/
4. Huang, Wentao, Liu, Hongjing, Lv, Tianzhu. 2021. Silencing of SETD6 inhibits the tumorigenesis of oral squamous cell carcinoma by inhibiting methylation of PAK4 and RelA. In Histology and histopathology, 36, 229-237. doi:10.14670/HH-18-327. https://pubmed.ncbi.nlm.nih.gov/33710605/
智鼠故事 
